That's what I could compile at first glance; other clues as

New Post Public Reply Private Reply Replies (1) Message Board
lorbas trding #30106
629
That's what I could compile at first glance; other clues as well, e.g. timing of the posts (bcgk posts something on w:o then it appears here soon after, and vice versa):


Posted On: 04/21/2020 1:48:38 AM Cytodynamite

Dr. Yang did not mention Leronlimab as being better than other drugs as some people said here yesterday.


bcgk schrieb am 21.04.20 07:53:48

Habe mich hier ausnahmsweise mal auf eine mir zugetragene Info verlassen, tut mir leid. Dr. Yang hat dies in diesem Interview nichts dazu gesagt. Werde dies beim nächsten Mal kennzeichnen, ärgerlich. Der Bericht im US TV dürfte demnach auch ziemlich sicher nichts mit dem Kursanstieg zu tun gehabt haben, was mich noch positiver stimmt. Es ändert weiterhin nichts, zurücklehnen und die nächsten Wochen genießen

CytoDyn $CYDY mit Blockbuster Potential WKN: A0YHA5 | wallstreet-online.de - Vollständige Diskussion unter:
https://www.wallstreet-online.de/diskussion/1...wkn-a0yha5




1) Cytodynamite = Giselle007

Psychodynamite: "Selling 25% of my stake at $1.25ish to get my daughter a nice apartment in Stockholm seems not that bad today."

https://investorshangout.com/post/view?id=5668332


My post #17377 :
Regarding "Stockholm" , just another "coincidence" I suppose:


"Selling 25% of my stake at $1.25ish to get my daughter a nice apartment in Stockholm seems not that bad today."


Giselle007 i

iHub Info
Membership Type
Suspended Until 09/10/2022 03:08:03 PM
Followed By 2
Posts 67
Boards Moderated 0
Alias Born 11/10/2019 04:22:36 AM

Personal Info
Age 38
Location Stockholm, Sweden
Investment Philosophy Buy low, sell high. Basically an anticyclic approach.
Investing only in biotech, tech stocks and real estate.
Occupation Lecturer at Stockholm University
Interests/Hobby Skiing, reading.

Read More: https://investorshangout.com/post/view?id=566...z6KoZm0WwB



2.) See my post #15532

Cytodynamite = bcgk



Just look at his December posts: the same style as bcgk (extreme negativity, but bragging about shares owned, then whining when SP drops 3ct etc.).

Most importantly, the obsession about " OTC fairy tale " that occurs both in his iHub and Hangout posts. I'm sure if the search feature was better, one would find many more similiarities.

iHub:

bcgk Wednesday, 10/02/19 08:43:00 AM
Re: None 0
Post #
46751
of 53345
I bought at an average of 42c. Then I doubled at 35c and 32c. But I still feel like having bought too early. Timelines pass by, NP holds bizarre CCs and no one understands anything afterwards.

Typical OTC crap , overpromising and underdelivering as key characteristics. Best joke ever heard is NPs latest approach of not being allowed to talk about licensing deal. He would have been a much better fairy tale teller ....I am really excited about how deep his incompetence will drive down the SP.


bcgk Thursday, 09/26/19 03:32:59 PM
Re: None 0
Post #
46486
of 53345
Yes, red again. Sub 30c Monday then....looking forward to next fairy tale show...


Also, fairy tale appears in another post (deleted), but still searchable with the iHub search feature and search for "fairy tale":

You are absolutely right. Typically OTC. Just incredible Cytodyn Inc. 11/10/2019 02:53:39 PM



Hangouts


Who should believe him? That´s absolutely ashaming. Every week the same...so close...any day...very soon...we are so great....and so on...and so on....

Licensing deal...still negotiating? Who believes that? I suspect that´s a typical OTC fairy tale ....when there is no deal until EOY, we should force him legally to outline negotiations....to be honest...I suspect there are no negotations at all.....NBA is worth nothing....but a good thing to start a nice play.

AIMO

Read More: https://investorshangout.com/post/view?id=560...z6BbVByNYv

The science is (hopefully) undoubtedly existent and a strong argument for investing. BUT the rest - Proactive videos, CEO´s ductus, overpromising underdelivering, shifting timelines, telling every week another story etc reminds me of typical OTC scam/ fairy tale whatsoever.

I just hope that the science is real even though I am strongly questioning why no one is really interested in that.

The RED FLAG couldnt be obiger and hardly anyone is concerned about Pestell selling? Where am I?

[obiger: German word, probably auto-correct, yet another clue!]

Read More: https://investorshangout.com/post/view?id=560...z6BbVyOZvu

My eyes see SP tank another time. Below 28c, what a shame.

Read More: https://investorshangout.com/post/view?id=560...z6BbZITUHV


1

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

iTLC Traffic Systems Expand Global Reach at APTA 2026

Updated Category News Views 126

APTA 2026: The Launchpad for Intelligent Traffic Control Forget the days of manual traffic chaos—by the sounds of it, smart intersections are ready to rule the roads. Today's chatter at APTA 2026 in Chicago was a whirlwind of ideas, all centered around how ICP DAS and Towards Buddha Co., Ltd. plan to shake up traffic management globally with their iTLC Intelligent...

Continue Reading
Main Street Merger Faces Scrutiny: What It Means for Shareholders

Updated Category News Views 51

Under the Radar, but Not for Long Ah, mergers—those grand gestures in corporate America that promise growth, synergy, and shareholder value. But not every deal is a head-turner; some fly under the radar until someone grabs the magnifying glass. And that's exactly what's happening with Main Street Financial Services Corp.'s (OTC: MSWV) proposed merger with First...

Continue Reading
China-Malaysia Youth Dialogue: Tackling Ocean Challenges

Updated Category News Views 75

Building Bridges Across Waters These aren't the afternoons of trading stocks, folks—this one dives into the depths of the ocean and the tumultuous waters between China and Malaysia. October 30 saw the China-Malaysia Youth Ocean Dialogue take place at the China Media Group Sanya Studio, bringing together some sharp minds from both nations, tackling something that goes...

Continue Reading
UBCF Strikes Big in Times Square with New Billboards

Updated Category News Views 142

From the Shadows to the Spotlight Ever seen someone step up to the plate and knock it out of the park? That's what the United Breast Cancer Foundation (UBCF) is doing by plastering their mission right across Times Square. Talk about grabbing the bull by the horns, eh? With not one, but two billboards now gracing one of the globe's most iconic public spaces, they've...

Continue Reading
NABEP's Strategic Push: 41 Rigs to Bolster Output

Updated Category News Views 213

On The Ground: NABEP's Expanding Venezuelan Presence Think of oil production as a high-stakes poker game where each drill and rig is a well-placed bet. North American Blue Energy Partners (NABEP) is going all in on Venezuela, boosting their rig fleet and pushing production capacity to new heights. Set your sights on November when NABEP's in-country fleet will hit 41 rigs...

Continue Reading
ModelBest & OpenBMB Unveil Open-Source OCR Models

Updated Category News Views 132

A New Frontier in Document Parsing Just when you thought document parsing couldn't get any more advanced, ModelBest and OpenBMB come along with a game-changing release: the MiniCPM-OCR series. This duo of dynamite models, MiniCPM-OCR 1.0 and Jev, is all about taking the efficiency and performance expectations for open-source OCR models up a couple of notches. If you're an...

Continue Reading
Zhimeng Biopharma Hits Key Milestone in ALS Drug Trial

Updated Category News Views 232

Pivotal Point for Zhimeng's ALS Efforts Folks, get this—Zhimeng Biopharma's rolling out the big guns here with a significant step forward in their ALS treatment quest. This company just wrapped up patient enrollment for their next-gen ALS drug, CB03-154. We're talking about 255 patients now on board for a Phase 2/3 trial. The ground's shaking a bit because this...

Continue Reading
HanAll F&B Pioneers New Path for Domestic Rice Noodles

Updated Category News Views 227

New Spin on an Old Favorite: Rice Noodles Forget about the same old wheat noodles clogging up the pantry. HanAll F&B is revamping the noodle game with a homegrown twist, setting sights on a future where Korean rice isn't just for steaming, soup, or sushi. This outfit from Taebaek, Gangwon, has got its hands deep in the rice flour, finessing a patent that aims to make...

Continue Reading
Bass Angler Matt Robertson Reels in Record $1.25M Prize

Updated Category News Views 91

A New Era for Bass Fishing Payouts Who would have thought we'd see the day when bass fishing turned out to be as lucrative as a Wall Street handshake? But here we are, with Matt Robertson hauling in a whopping $1.25 million prize at World Bass Enterprises' first "The Champions" Tournament. We're not talking chump change here—this is the real deal in a sport often...

Continue Reading
NIDS Aims Global with CES 2027, Boosts Sensor Supply

Updated Category News Views 189

Pushing Boundaries at CES 2027 Kicking into high gear, NIDS Co., Ltd. is eyeing the CES 2027 stage like it's their personal gold rush. Already a heavyweight in environmental sensors, the company is all set to seize fresh international opportunities and expand their B2B supply footprint worldwide. Already Turning Heads Founded back in 2000, NIDS ain't new to the sensor...

Continue Reading